PFI AND A&S SIGN ASPIRIN DEAL

EDISON, N.J. -- Pharmaceutical Formulations Inc. here, the second-largest maker of solid-dosage generic pharmaceuticals in the country, has entered an agreement with A&S Pharmaceutical Corp., Bridgeport, Conn., to sell and market A&S's 325-mg aspirin. A&S is the second-largest manufacturer of private-label aspirin in the United States. Charles E. LaRosa, PFI's president and chief executive officer,

EDISON, N.J. -- Pharmaceutical Formulations Inc. here, the second-largest maker of solid-dosage generic pharmaceuticals in the country, has entered an agreement with A&S Pharmaceutical Corp., Bridgeport, Conn., to sell and market A&S's 325-mg aspirin. A&S is the second-largest manufacturer of private-label aspirin in the United States. Charles E. LaRosa, PFI's president and chief executive officer, said in a prepared statement that "this agreement is expected to add over $5 millio

Register to view the full article

test - Advanced Registered User

Already a member? .